Erelzi Gets Approval from FDA, a Biosimilar to Enbrel
The US Food and Drug Administration on 30th August accepted Sandoz’s biosimilar to Amgen’s blockbuster Enbrel, which will be identified
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine